<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 06:52:13 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>How To Profit From The 'Next' Dubai</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</guid>
      <description><![CDATA[The Dubai World default is a matter of only $60 billion – mere peanuts when compared to other elements of the global financial crisis. It’s thus of concern only to those silly enough to invest in real estate there (and the European banks foolish enough to finance it.) For the rest of us, it is a useful reminder that sudden collapses don’t really come out of nowhere – they can be foreseen, and smart investors can plan for them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3679796>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 13:51:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</link>
    </item>
    <item>
      <title>Astral Heights - Targacept snares big licensing deal</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687195</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dec. 4--Targacept Inc.'s status as an independent, local company grew firmer yesterday with the stunning news of a potential $1.24 billion licensing agreement with AstraZeneca PLC. &lt;/li&gt;&lt;li&gt;The agreement covers Targacept's research breakthrough on treating depression with its TC-5214 drug compound. &lt;/li&gt;&lt;li&gt;Instead, Targacept's management used the leverage of its breakthrough to draw lucrative offers from the companies, said Don deBethizy, the president and chief executive of Targacept.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687195>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 09:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RAI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRGT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSCM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687195</link>
    </item>
    <item>
      <title>Evening Standard, London, market report column</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3677112</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dec. 1--Could London Stock Exchange be about to swap one emirate investor  for another? &lt;/li&gt;&lt;li&gt;A rumour spreading in the City today was that Abu Dhabi is looking to buy  the 21 percent holding which Dubai Borse snapped up two years ago. &lt;/li&gt;&lt;li&gt;Fears that the Borse  might be forced to sell the stake if Dubai's problems grow have weighed  heavily on the exchange's shares in the last three trading days.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3677112>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 17:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JSAIY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LSE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3677112</link>
    </item>
    <item>
      <title>ANALYSIS: Newton's first law: do not lose money</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3621585</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Despite being near-bottom of its sector over 12 months, the Newton Growth fund will not rush to tap into the recovery in financial stocks. &lt;/li&gt;&lt;li&gt;After speaking to Richard Wilmot, the manager of Newton Growth, one does not imagine Newton will be among them.&lt;/li&gt;&lt;li&gt;Newton Growth is first quartile over three years, ranked 42 out of 308 funds in the Investment Management Association UK All Companies sector.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3621585>[More...]</a>]]></description>
      <pubDate>Mon, 09 Nov 2009 09:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3621585</link>
    </item>
    <item>
      <title>Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--Targacept Inc. posted its first quarterly profit in nearly three years yesterday, bolstered in large part by a $10 million milestone payment by AstraZeneca PLC. &lt;/li&gt;&lt;li&gt;Targacept, based in Piedmont Triad Research Park in Winston-Salem, is developing drugs based on nicotine research to treat diseases of the central nervous system. &lt;/li&gt;&lt;li&gt;The payment was the result of Targacept's research in adult attention deficit/hyperactivity disorder involving its AZD3480 drug compound, also known as TC-1734.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613879>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</link>
    </item>
    <item>
      <title>Green Business Awards 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687939</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sponsor's foreword We all know the perils we face from climate change, and that the responsibility to act to avert them rests heavily with the business community, eaga is therefore proud to sponsor the Green Business Awards once again.&lt;/li&gt;&lt;li&gt;The number of submissions this time is more than four times what it was in 2007, and the superb quality of entries continues to make die task of judging extremely daunting.&lt;/li&gt;&lt;li&gt;And if we as businesses are to drive the low-carbon economy, we must both change the way that we do things and have the enterprise and innovation to help our customers do the same by adopting greener lifestyles.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687939>[More...]</a>]]></description>
      <pubDate>Sun, 01 Nov 2009 13:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687939</link>
    </item>
    <item>
      <title>AstraZeneca Q3 Net Income Up</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3592781</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;AstraZeneca, a UK-based pharmaceutical company, has reported a net income of $2.12 billion, or $1.46 per diluted share, for the third quarter ended September 30, 2009, compared to $1.74 billion, or $1.19 per diluted share, for the third quarter ended September 30, 2008.&lt;/li&gt;&lt;li&gt;Net income for the nine months ended September 30, 2009 was $5.98 billion, or $4.12 per diluted share, compared to $4.88 billion, or $3.33 per share, for the nine months ended September 30, 2008. &lt;/li&gt;&lt;li&gt;Total revenues were $23.86 billion for the nine months ended September 30, 2009, compared to $23.41 billion, for the prior-year period.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3592781>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 10:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3592781</link>
    </item>
    <item>
      <title>Earnings Preview: Bristol-Myers 3Q earnings report</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Bristol-Myers Squibb Co., the world's No. &lt;/li&gt;&lt;li&gt;The following is a summary of key developments and analyst opinion related to the period.&lt;/li&gt;&lt;li&gt;OVERVIEW: Growing competition for its top drugs threatens revenue for the maker of blood thinner Plavix, the world's second-bestselling medication, and psychiatric drug Abilify.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3568342>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</link>
    </item>
    <item>
      <title>Drug makers, CVS slammed for promos</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</guid>
      <description><![CDATA[Drug makers, CVS slammed for promos<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560042>[More...]</a>]]></description>
      <pubDate>Sun, 18 Oct 2009 21:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</link>
    </item>
    <item>
      <title>Business Highlights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3558392</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bank of America loses $2.24B as loan losses rise&lt;/li&gt;&lt;li&gt;CHARLOTTE, N.C. (AP) - Bank of America Corp. said Friday it lost more than $2.2 billion in the third quarter as loan losses kept rising, providing more evidence that consumers are still struggling to pay their bills.&lt;/li&gt;&lt;li&gt;The bank's total allowance for loan and lease losses now totals $35.83 billion.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3558392>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 22:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3558392</link>
    </item>
    <item>
      <title>Dampier Defends Woodford Income Strategy</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3556374</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Hargreaves Lansdown head of research Mark Dampier has defended Invesco Perpetual UK equity income guru Neil Woodford's performance, and says now is the best time to invest.&lt;/li&gt;&lt;li&gt;Woodford's pound 6.4bn income and pound 8.6bn higher-income funds are 17th and 18th respectively in the UK equity income and growth sector from January 1 to September 25, according to figures from Lipper.&lt;/li&gt;&lt;li&gt;However, Dampier says this is due to the manager's long-term, bearish economic outlook and stocks that match this view - namely those with strong balance sheets and stable business models such as AstraZeneca and GlaxoSmithKline.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3556374>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 09:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3556374</link>
    </item>
    <item>
      <title>BlackRock Completes Merger With Barclays Global Investors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3678000</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;BlackRock, Inc. (NYSE: BLK) today announced that it has completed its merger with Barclays Global Investors (&quot;BGI&quot;), including the market-leading iShares(R) exchange traded funds business. &lt;/li&gt;&lt;li&gt;The combined firm will operate under the BlackRock name and the iShares brand will be retained.&lt;/li&gt;&lt;li&gt;Both firms maintained strong core business momentum while achieving the close of an unprecedented merger in less than six months, commented Laurence D. Fink, BlackRock's Chairman and Chief Executive Officer.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3678000>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 22:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BLK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3678000</link>
    </item>
    <item>
      <title>BlackRock Completes Merger with Barclays Global Investors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3675662</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;BlackRock, Inc. (NYSE:BLK) today announced that it has completed its   merger with Barclays Global Investors (&quot;BGI&quot;), including the   market-leading iShares&amp;#174; exchange traded funds business. &lt;/li&gt;&lt;li&gt;Both firms maintained strong   core business momentum while achieving the close of an unprecedented   merger in less than six months,&quot; commented Laurence D. Fink, BlackRock's   Chairman and Chief Executive Officer.&lt;/li&gt;&lt;li&gt;In addition to risk factors previously disclosed in BlackRock's   Securities and Exchange Commission (&quot;SEC&quot;) reports and those identified   elsewhere in this report the following factors, among others, could   cause actual results to differ materially from forward-looking   statements or historical performance: (1) the introduction, withdrawal,   success and timing of business initiatives and strategies; (2) changes   and volatility in political, economic or industry conditions, the   interest rate environment or financial and capital markets, which could   result in changes in demand for products or services or in the value of   assets under management; (3) the relative and absolute investment   performance of BlackRock's investment products; (4) the impact of   increased competition; (5) the impact of capital improvement projects;   (6) the impact of future acquisitions or divestitures; (7) the   unfavorable resolution of legal proceedings; (8) the extent and timing   of any share repurchases; (9) the impact, extent and timing of   technological changes and the adequacy of intellectual property   protection; (10) the impact of legislative and regulatory actions and   reforms and regulatory, supervisory or enforcement actions of government   agencies relating to BlackRock, Barclays PLC, Bank of America   Corporation, Merrill Lynch &amp; Co., Inc. or The PNC Financial Services   Group, Inc.; (11) terrorist activities and international hostilities,   which may adversely affect the general economy, domestic and local   financial and capital markets, specific industries or BlackRock; (12)   the ability to attract and retain highly talented professionals; (13)   fluctuations in the carrying value of BlackRock's investments; (14)   fluctuations in foreign currency exchange rates, which may adversely   affect the value of investment advisory and administration fees earned   by BlackRock or the carrying value of certain assets and liabilities   denominated in foreign currencies; (15) the impact of changes to tax   legislation and, generally, the tax position of the Company; (16)   BlackRock's success in maintaining the distribution of its products;   (17) the impact of BlackRock electing to provide support to its products   from time to time; (18) the impact of problems at other financial   institutions or the failure or negative performance of products at other   financial institutions; and (19) the ability of BlackRock to integrate   the operations of Barclays Global Investors.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3675662>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 14:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BLK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3675662</link>
    </item>
    <item>
      <title>Softscape and Jobfox Deliver New Breakthrough Innovation for E-Recruitment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3626111</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Softscape,   the global leader in people   management software, and Jobfox,   the Internet's fastest-growing career site, have teamed to deliver a new   breakthrough innovation for e-recruitment. &lt;/li&gt;&lt;li&gt;This innovation, ResumePal,   is the new universal online standard job application that's seamlessly   integrated with Softscape's platform.&lt;/li&gt;&lt;li&gt;To help you create a new strategy for   managing hiring as the economy improves, the two companies are offering   a complimentary webinar, &quot;Preparing for the Next Job Hiring Wave&quot; on   Wednesday, November 18 at 2 p.m. ET.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3626111>[More...]</a>]]></description>
      <pubDate>Wed, 11 Nov 2009 13:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DLTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3626111</link>
    </item>
    <item>
      <title>Phase Forward Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data   management solutions for clinical trials and drug safety, today   announced its financial results for the third quarter of 2009.&lt;/li&gt;&lt;li&gt;Within total   revenues, electronic data capture (EDC) license, application hosting and   other related revenues were $38.5 million, representing 71% of third   quarter total non-GAAP revenues and an increase of 18% from $32.7   million in the prior year period.&lt;/li&gt;&lt;li&gt;Weiler added, &quot;During the third quarter, a pharmaceutical company in the   top 40 in sales selected Phase Forward's InForm EDC solution for a   multi-year, multi-million dollar commitment, while a leading provider of   information technology, consulting, and business process outsourcing   services selected InForm as part of their outsourcing services to a top   10 pharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591497>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 20:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFWD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</link>
    </item>
    <item>
      <title>Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3590187</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Mid-Atlantic Bio today announced that former Vermont Governor Howard   Dean will serve as the closing plenary speaker at the 2009 Mid-Atlantic   Bio Conference, November 4 through 6, held in Washington, D.C., at the   Washington, DC Convention Center. &lt;/li&gt;&lt;li&gt;Additionally, Representative Charles Boustany (R-La.) &lt;/li&gt;&lt;li&gt;Mid-Atlantic Bio is co-hosted by the region's most influential   life science and investor associations, MdBio Division of the Tech   Council of Maryland (TCM/MdBio), the Mid-Atlantic Venture Association   (MAVA), and the Virginia Biotechnology Association (VaBIO).&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3590187>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3590187</link>
    </item>
    <item>
      <title>AstraZeneca: Third Quarter and Nine Months Results 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3589901</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;AstraZeneca (STO:AZN) (LSE:AZN)&lt;/li&gt;&lt;li&gt;Third quarter revenue increased by 10 percent at constant exchange rates   (CER) to $8,200 million.&lt;/li&gt;&lt;li&gt;-Emerging Markets revenue was up 15 percent at CER; on track for   double-digit growth for the full year.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3589901>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NKTR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3589901</link>
    </item>
    <item>
      <title>POZEN Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3586340</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;POZEN Inc. (NASDAQ: POZN), today announced results for the   third quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;POZEN reported a net income of $6.7 million, or $0.22 per share on a   diluted basis, for the third quarter of 2009, compared to net loss of   $(7.9) million, or $(0.26) per share on a diluted basis, for the third   quarter of 2008.&lt;/li&gt;&lt;li&gt;Revenue for the third quarter ended September 30, 2008   totaled $11.1 million, resulting from the amortization of upfront   payments received pursuant to the collaboration agreements with   AstraZeneca and GlaxoSmithKline of $3.2 million, $7.5 million of revenue   for development work, and $0.4 million of royalties on sales of Treximet.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3586340>[More...]</a>]]></description>
      <pubDate>Wed, 28 Oct 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3586340</link>
    </item>
    <item>
      <title>Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bristol-Myers   Squibb Company (NYSE:BMY) today reported strong sales and earnings   growth for the third quarter 2009.&lt;/li&gt;&lt;li&gt;&quot;The performance in the third quarter of 2009 clearly shows the results   of our outstanding business performance, disciplined financial   management and overall strategic execution,&quot; said James   M. Cornelius, chairman and chief executive officer. &lt;/li&gt;&lt;li&gt;Third Quarter Performance                                                                                                                2009        2008        Change   Net Sales                                           $  5,487    $  5,254    4%       Net Earnings from Continuing Operations             $  966      $  588      64%      GAAP Diluted EPS from Continuing Operations            0.48        0.29     66%      Non-GAAP Diluted EPS from Continuing Operations        0.52        0.45     16%      ($ amounts in millions, except per share amounts)&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571548>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</link>
    </item>
    <item>
      <title>Merck Announces Third-Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571555</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Merck &amp; Co., Inc. today announced financial results for the third &lt;/li&gt;&lt;li&gt;Merck &amp; Co., Inc. Consolidated Results (In Millions Except Earnings per Common Share) Quarter Ended September 30 (Unaudited) &lt;/li&gt;&lt;li&gt;The following table shows the financial results for Merck &amp; Co., Inc.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571555>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571555</link>
    </item>
    <item>
      <title>Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3555150</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for   the third quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;With three quarters of 2009 revenue recorded, Cubist has tightened its   full year 2009 guidance for CUBICIN U.S. net revenue to between $520 and   $525 Million, which is within the range the company announced in   January. &lt;/li&gt;&lt;li&gt;Our strong top and bottom line results have   been achieved in an environment that has been tough for many branded   pharmaceuticals.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3555150>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3555150</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ABBI,AZN," rel="self" type="application/rss+xml" />
  </channel>
</rss>